Pharmacokinetic Behavior Of Montelukast In Indigenous Healthy Male Volunteers

Aim of present study was to investigate the pharmacokinetic behavior of Montelukast in the healthy male volunteers under indigenous conditions. One tablet of montelukast 10 mg was administered in each subject and blood at different time intervals. Concentration of montelukast in plasma samples was analyzed by high performance liquid chromatography method to calculate pharmacokinetic parameters. The plasma concentration of montelukast was in the range of 1.31-1.76 mu g/mL at 0.5-12 hours with C-max value of 1.59 +/- 0.16 mu g/mL at 3.71 +/- 0.64 hours. These values of plasma drug concentrations were above the minimum effective concentration of montelukast during the entire study hours. Absorption and elimination half-lives of the montelukast were evaluated as 2.52 +/- 0.54 hours and 2.63 +/- 0.35 hours, respectively. The volume of distribution and total body clearance of montelukast were investigated as 0.34 +/- 0.01 L/kg and 0.01 +/- 0.00 L/hr/kg, respectively. The pharmacokinetic parameters i.e. C-max, AUC, t(1/2), V-d and Cl-B of montelukast calculated in present study were found different as compared to that of the previous literature values which was due to genetic and environmental variation.